Literature DB >> 34257427

Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Hannele Yki-Järvinen1,2, Panu K Luukkonen3,4,5, Leanne Hodson6,7, J Bernadette Moore8.   

Abstract

The global prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically increased in parallel with the epidemic of obesity. Controversy has emerged around dietary guidelines recommending low-fat-high-carbohydrate diets and the roles of dietary macronutrients in the pathogenesis of metabolic disease. In this Review, the topical questions of whether and how dietary fats and carbohydrates, including free sugars, differentially influence the accumulation of liver fat (specifically, intrahepatic triglyceride (IHTG) content) are addressed. Focusing on evidence from humans, we examine data from stable isotope studies elucidating how macronutrients regulate IHTG synthesis and disposal, alter pools of bioactive lipids and influence insulin sensitivity. In addition, we review cross-sectional studies on dietary habits of patients with NAFLD and randomized controlled trials on the effects of altering dietary macronutrients on IHTG. Perhaps surprisingly, evidence to date shows no differential effects between free sugars, with both glucose and fructose increasing IHTG in the context of excess energy. Moreover, saturated fat raises IHTG more than polyunsaturated or monounsaturated fats, with adverse effects on insulin sensitivity, which are probably mediated in part by increased ceramide synthesis. Taken together, the data support the use of diets that have a reduced content of free sugars, refined carbohydrates and saturated fat in the treatment of NAFLD.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34257427     DOI: 10.1038/s41575-021-00472-y

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  204 in total

Review 1.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

Review 2.  From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.

Authors:  J Bernadette Moore
Journal:  Proc Nutr Soc       Date:  2019-03-29       Impact factor: 6.297

3.  Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium.

Authors:  Bradley C Johnston; Dena Zeraatkar; Mi Ah Han; Robin W M Vernooij; Claudia Valli; Regina El Dib; Catherine Marshall; Patrick J Stover; Susan Fairweather-Taitt; Grzegorz Wójcik; Faiz Bhatia; Russell de Souza; Carlos Brotons; Joerg J Meerpohl; Chirag J Patel; Benjamin Djulbegovic; Pablo Alonso-Coello; Malgorzata M Bala; Gordon H Guyatt
Journal:  Ann Intern Med       Date:  2019-10-01       Impact factor: 25.391

4.  Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.

Authors:  Ken Sato; Masahiko Gosho; Takaya Yamamoto; Yuji Kobayashi; Norimitsu Ishii; Tomohiko Ohashi; Yukiomi Nakade; Kiyoaki Ito; Yoshitaka Fukuzawa; Masashi Yoneda
Journal:  Nutrition       Date:  2014-12-24       Impact factor: 4.008

Review 5.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

Review 6.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.

Authors:  Hannele Yki-Järvinen
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-07       Impact factor: 32.069

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

8.  Vitamin D and nonalcoholic fatty liver disease.

Authors:  Zixuan Zhang; James L Thorne; J Bernadette Moore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2019-11       Impact factor: 4.294

Review 9.  Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Liang Liu; Ping Li; Yiqi Liu; Yilian Zhang
Journal:  Dig Dis Sci       Date:  2019-06-15       Impact factor: 3.199

Review 10.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

View more
  19 in total

1.  A three-organelle complex made by wrappER contacts with peroxisomes and mitochondria responds to liver lipid flux changes.

Authors:  Nicolò Ilacqua; Irene Anastasia; Andrea Raimondi; Philippe Lemieux; Thomas Q de Aguiar Vallim; Katalin Toth; Eugene V Koonin; Luca Pellegrini
Journal:  J Cell Sci       Date:  2021-11-02       Impact factor: 5.285

Review 2.  Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.

Authors:  Amedeo Lonardo; Alessandro Mantovani; Salvatore Petta; Amedeo Carraro; Christopher D Byrne; Giovanni Targher
Journal:  Nat Rev Endocrinol       Date:  2022-07-15       Impact factor: 47.564

Review 3.  The metabolic nature of inflammatory bowel diseases.

Authors:  Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-29       Impact factor: 73.082

4.  Dietary Ferulic Acid Ameliorates Metabolism Syndrome-Associated Hyperuricemia in Rats via Regulating Uric Acid Synthesis, Glycolipid Metabolism, and Hepatic Injury.

Authors:  Nanhai Zhang; Jingxuan Zhou; Lei Zhao; Ou Wang; Liebing Zhang; Feng Zhou
Journal:  Front Nutr       Date:  2022-06-30

5.  Childhood nutrient intakes are differentially associated with hepatic and abdominal fats in adolescence: The EPOCH study.

Authors:  Catherine C Cohen; Wei Perng; Traci A Bekelman; Brandy M Ringham; Ann Scherzinger; Kartik Shankar; Dana Dabelea
Journal:  Obesity (Silver Spring)       Date:  2022-02       Impact factor: 9.298

6.  Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease.

Authors:  Jue Jia; Ruoshuang Liu; Weiping Wei; Fan Yu; Xiawen Yu; Yirong Shen; Caiqin Chen; Zhensheng Cai; Chenxi Wang; Zhicong Zhao; Dong Wang; Ling Yang; Guoyue Yuan
Journal:  Front Physiol       Date:  2021-12-17       Impact factor: 4.566

7.  Metabolic indexes of obesity in patients with common mental disorders in stable stage.

Authors:  Xiaoling Li; Xiaojie Shi; Yukang Tan; Yang Yu; Chaohua Tang; Guohong Xu; Xinglian Zhang; Hairong Liao; Xiancong Mai; Wensheng Chen; Xin Luo; Caixia Xu; Guojun Xie; Jiaquan Liang
Journal:  BMC Psychiatry       Date:  2022-02-07       Impact factor: 3.630

8.  Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study.

Authors:  Tracy Bonsu Osei; Anne-Marieke van Dijk; Sjoerd Dingerink; Felix Patience Chilunga; Erik Beune; Karlijn Anna Catharina Meeks; Silver Bahendeka; Matthias Bernd Schulze; Charles Agyemang; Mary Nicolaou; Adriaan Georgius Holleboom; Ina Danquah
Journal:  Nutrients       Date:  2021-10-20       Impact factor: 5.717

Review 9.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10

10.  Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice.

Authors:  Youwen Yuan; Kangli Li; Fei Teng; Weiwei Wang; Bing Zhou; Xuan Zhou; Jiayang Lin; Xueru Ye; Yajuan Deng; Wenhui Liu; Shenjian Luo; Peizhen Zhang; Deying Liu; Minghua Zheng; Jin Li; Yan Lu; Huijie Zhang
Journal:  J Biol Chem       Date:  2022-04-18       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.